Crossmark

Hybrid particles derived from alendronate and bioactive glass for treatment of osteoporotic bone defects

Published Online: 2019

Authors

Diba, Mani

Camargo, Winston A.

Zinkevich, Tatiana

Grünewald, Alina

Detsch, Rainer

Kabiri, Yoones https://orcid.org/0000-0003-0721-0484
Kentgens, Arno P. M. https://orcid.org/0000-0001-5893-4488
Boccaccini, Aldo R.

van den Beucken, Jeroen J. J. P.

Leeuwenburgh, Sander C. G. https://orcid.org/0000-0003-1471-6133
Funding

Funding for this research was provided by:

Rijksdienst voor Ondernemend Nederland (SHM012014)
License Information

Accepted Manuscript valid from 2020-01-04
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Yoones Kabiri (ORCID)

: Arno P. M. Kentgens (ORCID)

: Arno P. M. Kentgens (ResearcherID)

: Sander C. G. Leeuwenburgh (ORCID)

: Sander C. G. Leeuwenburgh (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 20 November 2018; Accepted 26 December 2018; Accepted Manuscript published 4 January 2019; Advance Article published 11 January 2019; Version of Record published 30 January 2019

Document is current